XML 13 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue:        
Total revenues $ 30,235 $ 25,112 $ 79,992 $ 76,626
Operating expenses:        
Cost of revenue (642) (146) (1,022) (368)
Research and development (23,596) (41,058) (71,827) (121,753)
General and administrative (10,860) (17,275) (42,097) (50,947)
Fair value adjustments 318 1,863 387 1,863
Operating loss (4,545) (31,504) (34,567) (94,579)
Other income (expense):        
Non-operating income (expense) (19,298) 19 (19,574) 6,054
Gain from deconsolidation of MiNK Therapeutics, Inc. 100,924 0 100,924 0
Interest expense, net (13,170) (35,729) (39,254) (96,940)
Net income (loss) 63,911 (67,214) 7,529 (185,465)
Dividends on Series A-1 convertible preferred stock (54) (54) (162) (161)
Less: net loss attributable to non-controlling interest (3) (828) (3,164) (4,112)
Net income (loss) attributable to Agenus Inc. common stockholders $ 63,860 $ (66,440) $ 10,531 $ (181,514)
Per common share data:        
Basic net income (loss) attributable to Agenus Inc. comm stockholders $ 2 $ (3.08) $ 0.37 $ (8.65)
Diluted net income (loss) attributable to Agenus Inc. comm stockholders $ 1.94 $ (3.08) $ 0.37 $ (8.65)
Weighted average number of Agenus Inc. common shares outstanding:        
Basic 31,886 21,550 28,184 20,995
Diluted 32,858 21,550 28,264 20,995
Other comprehensive loss:        
Foreign currency translation loss $ (56) $ (346) $ (162) $ (392)
Other comprehensive loss (56) (346) (162) (392)
Comprehensive income (loss) 63,804 (66,786) 10,369 (181,906)
Research and Development Revenue [Member]        
Revenue:        
Total revenues 1,087 0 1,421 267
Service Revenue [Member]        
Revenue:        
Total revenues 0 454 1,036 1,353
Non-Cash Royalty Revenue Related to the Sale of Future Royalties [Member]        
Revenue:        
Total revenues $ 29,148 $ 24,658 $ 77,535 $ 75,006